S A Messer - JoVE Visualize

Showing results (91-100 of 108) with videos related to

Pageof 11

Sort By:

Diagnostic Microbiology and Infectious Disease|April 23, 1999

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|February 13, 1999

In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agentsM A Pfaller, S A Messer, S Gee, et al.

Journal of Clinical Microbiology|May 6, 2005

Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)M A Pfaller, S A Messer, L Boyken, et al.

Antimicrobial Agents and Chemotherapy|December 3, 1998

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|November 28, 2002

Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in TaiwanW-L Yu, R N Jones, R J Hollis, et al.

Antimicrobial Agents and Chemotherapy|February 19, 2000

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.

Diagnostic Microbiology and Infectious Disease|October 9, 1998

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panelM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|July 1, 1997

Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infectionS W Redding, M A Pfaller, S A Messer, et al.

Journal of Clinical Microbiology|November 20, 2009

Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida sppM A Pfaller, L Boyken, R J Hollis, et al.

Antimicrobial Agents and Chemotherapy|December 31, 1998

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and AfricaM A Pfaller, J Zhang, S A Messer, et al.

Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:

Pageof 11

Diagnostic Microbiology and Infectious Disease|April 23, 1999

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|February 13, 1999

In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agentsM A Pfaller, S A Messer, S Gee, et al.

Journal of Clinical Microbiology|May 6, 2005

Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)M A Pfaller, S A Messer, L Boyken, et al.

Antimicrobial Agents and Chemotherapy|December 3, 1998

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|November 28, 2002

Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in TaiwanW-L Yu, R N Jones, R J Hollis, et al.

Antimicrobial Agents and Chemotherapy|February 19, 2000

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.

Diagnostic Microbiology and Infectious Disease|October 9, 1998

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panelM A Pfaller, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|July 1, 1997

Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infectionS W Redding, M A Pfaller, S A Messer, et al.

Journal of Clinical Microbiology|November 20, 2009

Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida sppM A Pfaller, L Boyken, R J Hollis, et al.

Antimicrobial Agents and Chemotherapy|December 31, 1998

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and AfricaM A Pfaller, J Zhang, S A Messer, et al.

Pageof 11